248.00 €
×
Print or save as PDF
You will be redirected to your browser's interface for printing and saving as a PDF.
Choose the option that's best for you from the "Destination" drop-down menu.
Availability details
H221-50ug · Anti-Human/Mouse HGAL (Clone 1H1-A7) - Dylight® 594 - 50 µg
Available quantity : 0
The stock indication is not contractual: this data is constantly changing and may vary depending on the quantities requested.
H221-50ug · Anti-Human/Mouse HGAL (Clone 1H1-A7) - Dylight® 594 - 50 µg
HGAL (human germinal center-associated lymphoma) is a prognostic marker that predicts improved survival in patients with diffuse large B-cell or classic Hodgkin lymphoma1, 2, 3. HGAL protein is involved in several signaling pathways and cellular functions. HGAL decreases cell motility by interacting with F-actin and myosin II, inhibits the ability of myosin to translocate actin, and directly interacts with RhoA-specific guanine nucleotide exchange factors PDZ-RhoGEF and LARG4, 5, 6. HGAL also enhances intracellular B-cell receptor signaling by directly binding to Syk and enhancing Syk kinase activity7. Additionally, HGAL expression is upregulated after IL-4 stimulation8.
HGAL protein localizes to both the cell cytoplasm and membrane2, 4, 7, 9, with a major proportion localizing to lipid rafts9. Localization is modulated by BCR activation and is facilitated by myristoylation and palmitoylation protein modifications9. Additionally, IL-6 induces HGAL phosphorylation and relocalization to podosome-like structures4.
The anti-HGAL 1H1-A7 antibody was generated by immunizing mice with a GST-HGAL fusion protein and then fusing draining lymph node or spleen cells to K6H6B5 fusion partner hybridoma cells2. Hybridoma supernatants were screened by ELISA, subcloned, and then further screened by immunoblotting cellular lysates from stably transfected Daudi and HeLa cells expressing HGAL. 1H1-A7 is an IgG2a antibody containing a κ light chain. Human HGAL and its homologous mouse protein M17 are highly conserved but have some differences in expression pattern8. A comparison of real-time PCR and Western blotting data show a strong correlation between HGAL mRNA expression and protein abundance2.
- Product categories: Primary Monoclonal Antibodies
- Pkg Size: 50 µg
- Clone: 1H1-A7
- Research Area: Cancer, Immuno-Oncology, Immunology, Oncology
- Antigen Distribution: HGAL is expressed in germinal center (GC) lymphocytes, spleen, thymus, and many lymphoma subtypes, predominantly in GC-derived lymphomas and particularly in B-cell and Hodgkin lymphomas.
- Applications: ELISA, IF Microscopy, IHC, IP, WB
- Concentration: 0.2 mg/ml
- Formulation: This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
- Storage and Stability: This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.
HGAL protein localizes to both the cell cytoplasm and membrane2, 4, 7, 9, with a major proportion localizing to lipid rafts9. Localization is modulated by BCR activation and is facilitated by myristoylation and palmitoylation protein modifications9. Additionally, IL-6 induces HGAL phosphorylation and relocalization to podosome-like structures4.
The anti-HGAL 1H1-A7 antibody was generated by immunizing mice with a GST-HGAL fusion protein and then fusing draining lymph node or spleen cells to K6H6B5 fusion partner hybridoma cells2. Hybridoma supernatants were screened by ELISA, subcloned, and then further screened by immunoblotting cellular lysates from stably transfected Daudi and HeLa cells expressing HGAL. 1H1-A7 is an IgG2a antibody containing a κ light chain. Human HGAL and its homologous mouse protein M17 are highly conserved but have some differences in expression pattern8. A comparison of real-time PCR and Western blotting data show a strong correlation between HGAL mRNA expression and protein abundance2.
- Product categories: Primary Monoclonal Antibodies
- Pkg Size: 50 µg
- Clone: 1H1-A7
- Research Area: Cancer, Immuno-Oncology, Immunology, Oncology
- Antigen Distribution: HGAL is expressed in germinal center (GC) lymphocytes, spleen, thymus, and many lymphoma subtypes, predominantly in GC-derived lymphomas and particularly in B-cell and Hodgkin lymphomas.
- Applications: ELISA, IF Microscopy, IHC, IP, WB
- Concentration: 0.2 mg/ml
- Formulation: This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
- Storage and Stability: This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.
Suggested application(s)ELISA, Immunofluorescence and cell labelling, Immunohistochemistry (IHC), Immunoprecipitation, Western blot and immunodetection
Clone1H1-A7
Marker594, Dylight®
Storage temperature+4°C
Quantity50 ug
You may be also interested in these categories
Primary antibodyA5-OX-I6ASecondary antibodies, anti-tag antibodies, and streptavidinSecondary antibodies fluorescent markerFluorescent reactive markerFluorescent markerFluorescent protein, nucleotide, and other conjugateMarker for antibody and proteinAmino reactive markerAntibody marker and standard proteinFluorescent marker, reactive marker, biotinylation reagentNucleotide labelBiotin, conjugated streptavidinConjugated alkaline phosphataseSmall molecule markerBiotinylation reagent
The stock indication is not contractual: this data is constantly changing and may vary depending on the quantities requested.